Drug Trial Radar · NCT03762265
A Study of PRN1008 in Patients With Pemphigus
Last checked: Nov 20, 2026Latest source record: Aug 2, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
131
Actual
Start
Jan 8, 2019
Primary completion
Jul 30, 2021
Study completion Dec 17, 2021
Sponsor
- Lead sponsor
- Principia Biopharma, a Sanofi CompanyIndustry
- Sponsor type
- Industry
- First posted
- Dec 3, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This was a Phase 3 randomized, parallel-group, double-blind, placebo-controlled trial (blinded treatment \[BT\] period) followed by an open-label extension \[OLE\] period intended to evaluate the efficacy and safety of oral PRN1008 in moderate to severe pemphigus. After completing the open-label extension period, eligible participants might continue in a long term extension (LTE) Period of 48 weeks.
Conditions
- Pemphigus
Interventions
RilzabrutinibDrug
Pharmaceutical form: Tablet Route of administration: Oral
PlaceboDrug
Pharmaceutical form: Tablet Route of administration: Oral
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Who Achieved Complete Remission (CR) With a Corticosteroids Dose of Less Than or Equal to (<=) 10 mg/Day From Week 29 to Week 37: Pemphigus Vulgaris Participants in Modified Intent-to-Treat (PV mITT) PopulationTime frame: From Week 29 to Week 37
- Percentage of Participants Who Achieved Complete Remission With a Corticosteroids Dose of <=10 mg/Day From Week 29 to Week 37: Modified Intent-to-Treat (mITT) PopulationTime frame: From Week 29 to Week 37
Locations
88 sites in 19 countries. Site status is shown where the registry gives one.
Central Recruiting (Principia Biopharma)
Boca Raton, Florida
Central Recruiting (Principia Biopharma)
Coral Gables, Florida
Central Recruiting (Principia Biopharma)
Atlanta, Georgia
Central Recruiting (Principia Biopharma)
Ann Arbor, Michigan
Central Recruiting (Principia Biopharma)
Ann Arbor, Michigan
Central Recruiting (Principia Biopharma)
Rochester, Minnesota
Central Recruiting (Principia Biopharma)
Albuquerque, New Mexico
Central Recruiting (Principia Biopharma)
New York, New York
Central Recruiting (Principia Biopharma)
New York, New York
Central Recruiting (Principia Biopharma)
Chapel Hill, North Carolina
Central Recruiting (Principia Biopharma)
Durham, North Carolina
Central Recruiting (Principia Biopharma)
Cleveland, Ohio
Central Recruiting (Principia Biopharma)
Austin, Texas
Central Recruiting (Principia Biopharma)
Murray, Utah
Central Recruiting (Principia Biopharma)
Buenos Aires, Argentina
Central Recruiting (Principia Biopharma)
Buenos Aires, Argentina
Central Recruiting (Principia Biopharma)
San Nicolás, Argentina
Central Recruiting (Principia Biopharma)
Melbourne, Australia
Central Recruiting (Principia Biopharma)
Sydney, Australia
Central Recruiting (Principia Biopharma)
Fremantle, Western Australia, Australia
Central Recruiting (Principia Biopharma)
Campinas, Brazil
Central Recruiting (Principia Biopharma)
Campo Grande, Brazil
Central Recruiting (Principia Biopharma)
Ribeirão Preto, Brazil
Central Recruiting (Principia Biopharma)
Pleven, Bulgaria
Central Recruiting (Principia Biopharma)
Plovdiv, Bulgaria
Central Recruiting (Principia Biopharma)
Sofia, Bulgaria
Central Recruiting (Principia Biopharma)
Winnipeg, Manitoba, Canada
Central Recruiting (Principia Biopharma)
Osijek, Croatia
Central Recruiting (Principia Biopharma)
Zagreb, Croatia
Central Recruiting (Principia Biopharma)
Bobigny, France
Central Recruiting (Principia Biopharma)
Bordeaux, France
Central Recruiting (Principia Biopharma)
Lille, France
Central Recruiting (Principia Biopharma)
Pierre-Bénite, France
Central Recruiting (Principia Biopharma)
Rouen, France
Central Recruiting (Principia Biopharma)
Toulouse, France
Central Recruiting (Principia Biopharma)
Berlin, Germany
Central Recruiting (Principia Biopharma)
Dresden, Germany
Central Recruiting (Principia Biopharma)
Düsseldorf, Germany
Central Recruiting (Principia Biopharma)
Erlangen, Germany
Central Recruiting (Principia Biopharma)
Heidelberg, Germany
Showing 40 of 88 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.